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Abstract
For most complex traits, results from genome-wide association studies show that the proportion of the phenotypic variance
attributable to the additive effects of individual SNPs, that is, the heritability explained by the SNPs, is substantially less than
the estimate of heritability obtained by standard methods using correlations between relatives. This difference has been
called the ‘‘missing heritability’’. One explanation is that heritability estimates from family (including twin) studies are biased
upwards. Zuk et al. revisited overestimation of narrow sense heritability from twin studies as a result of confounding with
non-additive genetic variance. They propose a limiting pathway (LP) model that generates significant epistatic variation and
its simple parametrization provides a convenient way to explore implications of epistasis. They conclude that over-
estimation of narrow sense heritability from family data (‘phantom heritability’) may explain an important proportion of
missing heritability. We show that for highly heritable quantitative traits large phantom heritability estimates from twin
studies are possible only if a large contribution of common environment is assumed. The LP model is underpinned by
strong assumptions that are unlikely to hold, including that all contributing pathways have the same mean and variance
and are uncorrelated. Here, we relax the assumptions that underlie the LP model to be more biologically plausible. Together
with theoretical, empirical, and pragmatic arguments we conclude that in outbred populations the contribution of additive
genetic variance is likely to be much more important than the contribution of non-additive variance.
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Introduction
A finding from genome-wide association studies for most complex
traits is that the proportion of the phenotypic variance attributable
to the additive effects of individual SNPs, i.e. the heritability
explained by the SNPs, is substantially less than the estimate of
heritability obtained from correlations of relatives using family data.
Many explanations for this so-called ‘missing heritability’ have been
proposed [1,2,3,4,5]. One explanation is that heritabilities from
family (including twin) studies are overestimated. The problem of
bias in heritability estimates has been much discussed in the
quantitative genetic literature (e.g., [6,7,8,9]). For example, in the
classical twin design of monozygotic (MZ) and dizygotic (DZ) twin
pairs, there are only three essential statistics that can be estimated
from their phenotypes, namely the MZ resemblance (such as
covariance or correlation), the DZ resemblance, and the overall
phenotypic variation in the sample. Therefore, only three variance
components can be estimated, although many more genetic and
non-genetic causal components of variance can be postulated to
influence MZ and DZ resemblance. It is well recognized that
estimates of heritability may be biased and that it is difficult to
separate additive genetic from non-additive genetic components
and to separate genetic from common (or shared) family
environment components (e.g., [6,7,8,9]). Estimates of heritability
using phenotypic data from very distantly related individuals may
have trivial bias from epistatic or common environment compo-
nents compared to additive genetic components but are subject to
very large sampling error. Human studies of distantly related
individuals of sufficient size are simply not achievable. For disease
traits, ascertainment bias in sampling of families for estimation of
recurrence risks has long been recognized as a possible cause of
inflated estimates of heritability [10,11]. Lastly, estimates of
heritability for disease traits from twin cohorts (collected in restricted
clinical settings) may be higher than those estimated from national
cohort data, these differences most likely reflecting environmental
factors including clinical practice [12].
Recently, Zuk et al. [13] revisited the overestimation of narrow
sense (additive) heritability from family studies that could result
from confounding with non-additive genetic variance. They
referred to the difference between the expected value of the
heritability estimated from family data and the ‘true’ heritability as
‘phantom heritability’. To illustrate their arguments, they
proposed a limiting pathway (LP) model in which there are k
pathway phenotypes, which are unobserved intermediate pheno-
types. The phenotypically expressed trait value of an individual is
the maximum of the individual pathway values. This model, they
suggest, may be representative of biological processes that depend
on the rate-limiting value among multiple inputs, ‘such as the
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levels of components of a molecular complex required in
stoichiometric ratios, reactants required in a biochemical pathway,
or proteins required for transcription of a gene’. Under their LP
model, each pathway phenotype includes only additive genetic
effects but, for kw1, non-additive genetic variance is generated for
the expressed phenotype, and so the heritability of this phenotype
is less than the expected estimate from a classical twin design
analysis. As the magnitude of epistasis depends on k, the LP model
provides a convenient way to explore the possible contribution of
non-additive variation to missing heritability. They use this model
to illustrate that over-estimation of heritability from pedigree data
may explain an important proportion of missing heritability, but
that quantifying this from available data is difficult. They advocate
the continuation of association studies but argue that results should
be reported acknowledging that heritabilities quoted from family
studies may be overestimated. Nonetheless, their results may
impact on the design of experiments seeking to identify disease or
trait associated variants. It is therefore important to gauge
carefully the likely relevance of their results.
Zuk et al. [13] consider their model to be simple and
biologically natural. Their model is indeed simple and it usefully
explores an epistatic model without needing to define genotypic
effects at individual loci, because an infinitesimal model is assumed
for each pathway. The pathways are assumed to be genetically
independent and to have equal heritability, mean and variance.
These are strong assumptions which may not be biologically
plausible. For example, in human cells protein concentrations can
be correlated and have different variances [14]. As complex traits
are affected by many genes, individual genes will typically affect
many complex traits [15,16]. Similarly, a single gene could affect
multiple pathways, thereby creating a dependency between the
affected pathways.
The purpose of this paper is twofold. First, we show that under
the basic LP model, highly heritable quantitative traits produce
phantom heritability only if the contribution of common variance
is relatively large. Second, we explore the impact of the
assumptions underlying the basic LP model. We extend the basic
LP model to determine if their conclusions also hold after relaxing
some assumptions to obtain a more biologically plausible model.
Finally, we interpret the LP model in the context of other
published studies.
Methods
Notation
Where convention allows, we use Greek symbols for population
parameters and Roman for their estimates. In other cases we use a
hat ( ˆ ) notation to distinguish estimates from population
parameters. Moreover, we use h2 to represent the parameter of
narrow sense heritability and h2pop to represent the expected value
of the heritability estimated from phenotypic data collected in the
population. Here we consider estimation of h2pop from twin data
under the ACE (additive genetic, common environment, unique
environment) model, which we denote with h2pop(ACE). Similarly,
we use c2 and c2pop(ACE) for the parameter and the expected value
of its estimate of the proportion of variance attributable to the
common environment under the ACE model.
The classical Twin Model
Like Zuk et al., we explore the LP genetic architecture through
the variance components of the classical twin model. Under this
model, only three independent parameters can be estimated from
sets of MZ and DZ twins. One set of parameters is the phenotypic
variance s2P, the MZ correlation rMZ and DZ correlation rDZ .
For MZ twins rMZ~(s
2
Gzs
2
C)=s
2
P with s
2
G representing the total
genetic variance and s2C the variance attributable to the common
environment. The genetic variance can be broken down into
additive s2A and non-additive components s
2
NA~s
2
Dzs
2
AA
zs2ADz:::, the sum of all epistatic genetic variance components,
with dominance represented by the subscript D. For DZ twins the
phenotypic correlation is rDZ~(
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tability under the ACE model is estimated as
h^2pop(ACE)~2(rMZ{rDZ) and the proportion of variance attribut-
able to common environmental effects as c^2ACE~2rDZ{rMZ .
As well recognized [7,8,7,9], h2pop(ACE) is an upwardly biased
estimate of the narrow sense heritability h2~s2A=s
2
P. Likewise,
when non-additive genetic variance is present c2pop(ACE) is a
downwardly biased estimate of c2~s2C=s
2
P, but if 2rDZwrMZ we
can conclude that common environment plays a role (c^2w0). Also
recognized in the quantitative genetics literature [7,6,9], and
concluded by Zuk et al. [13], it is impossible to disentangle the
contribution of epistasis and common variance based only on twin
data. However, there are bounds on some parameters (and hence
their estimates). From the equations provided above and by
americanrecognizing that variance components are non-negative,
that variance components sum to s2P, and that MZ and
DZ correlations are bounded between 0 and 1, some
bounds are s2NA=2s
2
Pƒ(rMZ{2rDZzs2C=s2P)ƒs2NA=s2P, and
2rDZ{rMZƒs2C=s2P. In the absence of dominance and epistasis
the lower bound of rDZ is rDZ~
1
2
rMZz
1
2
s2C=s
2
P. We use these
bounds to show in circumstances in which a large contribution
from variance from epistasis is possible only if there is a large
contribution to the variance from common environment. Whether
this is plausible is trait dependent.
The basic LP Model
In the basic LP model for continuous traits [13], the final
observed phenotype P is defined as the maximum (or equivalently
the minimum) of k independent intermediate pathway pheno-
types, Pmax~max(P1,:::,Pk). The intermediate phenotypes Pi are
completely additive, but the final phenotype Pmax is not if kw1.
Zuk et al. [13] assumed an infinitesimal model for each pathway,
so the basic LP model has three parameters: the number of
(additive) genetic pathways k, the heritability of each pathway
h2path assumed to be constant across pathways, and the proportion
of environmental variance s2[path which is common among full
siblings (including MZ and DZ twins) cpath~s
2
Cpath
.
s2[path (csib in
[13]). For computational convenience the parameter cpath in the
LP model is a proportion of the environmental variance to ensure
a range between 0 and 1 independent of the value of h2path. This
should not be confused with the previously defined common
variance c2 which is proportional to the phenotypic variance.
When kw1, the heritability h2 of the expressed phenotype
differs from the pathway heritability h2path, likewise the proportion
of environmental variance which is due to common environment
in the pathway (cpath) is not necessarily equivalent to the analogous
quantity at the final phenotype level (c). The basic LP model
generates no dominance variance, but generates additive 6
additive variance between loci from different pathways.
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The Extended LP Model
In the basic LP model there are four important assumptions. All
pathway phenotypes (i) have the same mean, (ii) the same variance
(specifically N(0,1)), (iii) the same heritability, and (iv) are
independent at the pathway level. As these assumptions are
unlikely to be upheld in biological systems, we extend the basic LP
model by relaxing some of them. In this extended LP model the
means, variances and heritabilities may differ, and are defined by,
respectively, Dmpath~(m1,:::,mk), s
2
path~(s
2
P1
,:::,s2Pk ) and
h2path~(h
2
1,:::,h
2
k). A general correlation matrix could be defined
for the genetic relationship between pathways, but for simplicity
we assume a uniform genetic correlation between all pathways,
rpath when pathways are all positively correlated. Strong negative
correlations between all pathways are not possible in general, so
we consider the impact of negative correlations between pathways
by dividing the pathways into two equally divided sets which are
positively correlated by r within a set but negatively correlated by
rpath between the sets.
The phenotype of pathway i (Pi) can be partitioned into additive
genetic (Ai) and environmental (Ei) effects, Pi~AizEi. No
contribution of common environment is assumed between parents
of the same child. The additive genetic variance in pathway i is
s2Ai~s
2
Pi
h2i , and s
2
i
~s2Pi (1{h
2
i ). Illustrating for k~2, the additive
effects for both mothers and fathers are distributed as
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 
*N m1
m2
 
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 ! !
The (unique) environmental (stochastic) effects for parents are
assumed to be independent for each pathway and are distributed as
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As random mating is assumed, for offspring within a nuclear
family the phenotype of pathway i for sibling j can be partitioned as
Pi(j)~A
of f spring
i (j)zCizUi(j)
since the additive genetic pathway values of an offspring are
distributed with bivariate Mendelian sampling variance about the
mean additive genetic values of their parents. Ci is the environ-
mental effect of pathway i common to all siblings in a family,
Ci
~N (0,s2Ci ), and Ui(j) is the environmental effect unique to sibling
j, so for k~2,
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The proportion of environmental variance common for siblings
at the pathway level is cpath (assumed to be the same for each
pathway, and therefore the proportion of variance explained by
common environment is s2Ai~s
2
Pi
h2i hence s
2
Ui
~ 1{cpath
 
s2ei
Therefore, the extended LP model is a six parameter model:
LPext(k,Dmpath,s
2
path,h
2
path,cpath,rpath). For example, the limiting
pathway model LP(k~2,h2path~0:8,cpath~0:5) could be modeled
with the extended LP model as LPext(k~2,Dmpath~(0,0),
s2path~(1,1),h
2
path~(0:8,0:8),cpath~0:5,rpath~0). Zuk et al. [13]
showed that the narrow-sense heritability of the observed
phenotype in the population is h2~kr2P1,Ph
2
path, where rP1,P is
the correlation between the first pathway phenotype and the final
phenotype. This definition assumes exchangeability and indepen-
dence of the intermediate pathway phenotypes Pi. Under the
extended LP model, the pathway phenotypes are non-exchange-
able and correlated. As the additive model assumes
P~mz
Pk
i~1 biAize, we can estimate the pathway coefficients
b^i by regressing final phenotype P on the pathway genetic values
Ai. The heritability estimate is a function of the regression
coefficients, the additive values and the phenotype variance:
h^2all~Var(
Pk
i~1 b^iA^i)=s^
2
P. Unbiased estimates of h
2
all and
h2pop(ACE) are reported as the mean of h^
2
all and h^
2
pop(ACE) across
simulation replicates. As defined in Zuk et al. [13], the phantom
heritability is h2phantom~1{h
2
all=h
2
pop(ACE).
Simulation
For all simulations, we generated 50 independent samples of
100,000 families. Each family comprised two parents, an offspring,
its MZ twin and its DZ twin. The phenotype of a parent for pathway
i (Pi) was simulated asPi~AizEi. With randommating of parents,
the phenotype of an offspring j for pathway i was simulated as
Pi(j)~A
of f spring
i (j)zCizUi(j)
with Ai, Ei, A
offspring
i (j), Ci, and Ui(j) drawn from their
respective multivariate distributions. For monozygotic twins
A
offspring
i (j)=A
offspring
i (j
0). In all simulations, unless stated otherwise,
the following parameters were used: LPext(k~2,Dmpath~(0,0),
s2path~(1,1),h
2
path~(0:8,0:8),cpath~0:5,rpath~0). From the final
phenotypes of the offspring, the twin correlations rMZ and rDZ
were calculated, resulting in a heritability based on the ACEmodel of
h^2pop(ACE)~2(rMZ{rDZ) and phantom heritability
h^2phantom~1{h^
2=h^2pop(ACE). The reported h
2, c2, rMZ , rDZ , and
h2phantom are means across 50 simulation replicates and hence
unbiased.
We first performed simulations to study the implications of the
basic LP model with respect to common environmental effects. To
explore bounds on variance components we simulated a range of
basic LP models (h2i [½0:1,0:9,cpath~½0:1,0:9,k[f1,4g), and
calculated h2 and c2 for each model. From each simulation we
estimated rMZ and rDZ and plotted h
2 and c2 as a function of rMZ
and rDZ .
Subsequently we performed five simulations to study the effect
of differences in (i) pathway mean, (ii) variance, and (iii) heritability
on phantom heritability, and (iv & v) the effect of correlations
between pathways on phantom heritability in the extended LP
model. Simulations (i) to (iii) comprise a series of two-pathway
models in each of which one parameter was changed: (i) the
difference in pathway mean (m2{m1). These values are in standard
Limiting Pathway Models
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deviation units since s2Pi~1. (ii) The pathway variances differed,
s2P1~1 and s
2
P2
was varied. (iii) The pathway heritabilities differed,
h21~0:8 and h
2
2 was varied. (iv) In this case a multiple pathway
model was simulated with no common environment effects (i.e.,
cpath~0), in which both the pathway correlations rpath and
number of pathways k were varied. (v) As (iv), but with 10% of the
variance of each pathway attributed to common environment
(i.e.,cpath~0:5 when h
2
path~0:8).
Finally, to illustrate the extended LP model, we chose three
continuous traits with different ACE-based heritability estimates
from studies found in a recent twin research review paper [17]: (i)
height in Danish male twins (rMZ~0:89,rDZ~0:47,
h^2pop(ACE)~0:84)[18], (ii) triglyceride levels in blood in Swedish
female twins from 20–29 years old (rMZ~0:89,
rDZ~0:47,h
2
ACE~0:84)[19], and (iii) high-fat dairy intake in UK
male and female twins adjusted for age (rMZ~0:23,
rDZ~0:13,h^
2
pop(ACE)~0:20)[20]. Based on these observed values
and for different combinations of k[f2,4,10g and rpath[f0,0:2g,
we report the estimates h^2phantom, h^
2
all , and t c^
2. As rMZ and rDZ are
not model parameters but model outputs, the input parameters
h2path and cpath were chosen such that estimated rMZ and rDZ , based
on the median of 50 simulations, reflected the observed values.
Results
Exploring Bounds of Variance Components
Although it is impossible to disentangle the contribution of non-
additive genetic variance and common variance from twin data,
there are some bounds on these parameters as illustrated in
Figure 1, generated under the basic LP model, which is shown to
yield more extreme non-additive genetic variance than many
extended LP models. Each point in Figure 1 represents h2all or c
2 as
a function of rMZ , rDZ and k.
In comparisons of the left (k~1) with the right panels (k~4),
each combination of rMZ and rDZ values is consistent with
multiple basic LP models. In other words, the number of pathways
cannot be derived from a pair of rMZ and rDZ values alone. As
expected, for any rMZ and rDZ combination, the non-additive
variance increases with the number of pathways, resulting in a
lower narrow-sense heritability (h2all ) estimate for an epistatic
model (k~4) compared to the additive model (k~1) (panels A vs
B). However, the contribution of environmental variance which is
common for siblings (c) increases as well (panels C vs D).
Therefore, as 2rDZ{rMZ increases for complex traits, important
contributions from non-additive variance can be achieved only if
accompanied by high c2. For example, if rMZ~0:8 and
rDZ~0:4, an additive model (k~1; h
2~0:8) implies no contri-
bution of common variance (c2~0), whereas an highly epistatic
model (e.g., k~4; h2[½0:2{0:4) is consistent only with c2w0:2.
More generally, for highly heritable traits (h2w0:6; k~1) a large
amount of epistasis (h2v0:4; k~4) is consistent only with c2w0:2.
However, if
rMZ
2
wrDZ then substantial phantom heritability need
not be accompanied by large c2.
Properties of the Extended LP Model
Simulation results of the extended LP model are reported in
Figure 2 for the effect of different parameters on the phantom
heritability: (i) As the offset in mean between the two pathways
increases, the phantom heritability decreases (panel A). One
standard deviation difference in mean between pathway pheno-
types (if k~2) approximately halves the phantom heritability.
Clearly, as differences in offset become large, some pathways
contribute little to the final phenotype, effectively decreasing the
number of contributing pathways and hence the amount of
epistasis. (ii) Differences in phenotypic variance between two
pathways had no effect on phantom heritability (result not shown),
because large phenotypic variance not only increases the
probability of producing a maximum value, but also increases
the probability of producing a minimum value. Across individuals
both pathways contribute equally to the observed phenotype, but
the mean and variance of the observed phenotype increases.
Although the correlation between the final phenotype and the
pathway phenotypes is higher for the pathway with the higher
variance, the variance of the observed phenotype increases
proportionally with the ratio of the two pathway variances,
resulting in a constant heritability. (iii) As panel B shows,
differences in heritability between pathway phenotypes have only
a marginal effect on phantom heritability. (iv and v) Correlations
between pathways affect the phantom heritability significantly
(panels C and D). Positive correlations between pathways
effectively limit the amount of epistasis, resulting in less phantom
heritability. The larger the number of pathways, the larger the
phantom heritability reduction (for any given pathway correla-
tion). As the correlation between pathways approaches 1, the
model approaches an additive single pathway model. This holds
irrespective of the amount of common variance assumed, although
common variance increases the phantom heritability slightly
(panels D vs C). These results show that relaxing the assumptions
of equal mean and uncorrelated pathways can substantially reduce
the amount of phantom heritability. In contrast, negative
correlations increase the amount of epistasis even if only one out
of the k pathways is negatively correlated to the remaining
positively correlated pathways, although the relative impact
decreases as k increases (panels C and D).
Illustration for Three Traits
Table 1 shows the implications of the (extended) LP model for
three continuous traits with increasing estimated heritability: high-
fat dairy intake (h2pop(ACE)~0:2), triglyceride levels in blood
(h2pop(ACE)~0:54), and height (h
2
pop(ACE)~0:84). The table illus-
trates two important points. First, assuming a larger amount of
epistasis (i.e., larger k), not only implies increased phantom
heritability and decreased narrow-sense heritability, but also
implies a larger contribution of common variance. Second,
assuming positive dependence between pathways (rpathw0)
reduces the amount of epistasis. In other words, increasing the
number of pathways has less effect on phantom heritability,
narrow-sense heritability, and the contribution of common
variance, compared to a model with rpath~0. Especially for traits
with a large estimated ACE heritability, a high phantom
heritability (h^2phantomw0:61) is only compatible with a scenario in
which the percentage of common variance is high (c^2w0:39).
Nonetheless, in some scenarios important phantom heritability
is expected with negligible c^2, for example when k=2, rpath~0 we
estimate h2phantom to be 0.25 and c^
2~0:07. We note that we
selected examples with rMZ{2rDZv0 to illustrate potential
implications of the LP model. Hill et al. [21] reported an empirical
distribution of rMZ{2rDZ distributed around zero, with inter-
pretation that the distribution reflected sampling variance given
the often small sample size. However, direct interpretation of the
point estimates suggests that, since rMZ{2rDZv0 in ,50% of
cases, in these cases substantial phantom heritability could be
Limiting Pathway Models
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present in the context of zero or weak common environmental
variance.
Discussion
Bounds of Variance Components in Twin Studies
Using the basic LP model we explored constraints on
combinations of parameters. For additive models (Figures 1A
and 1C) all combinations of rMZ and rDZ lie in a region bounded
by rDZ~
1
2
rMZ (if c~0) and rMZ =rDZ (if c~1). For epistatic
models (Figures 1B and 1D) the bounds are evident from the
wedge shape of permissible combinations of rMZ and rDZ in
Figure 1. They show that when rDZ.
1
2
rMZ , substantial non-
additive genetic variance can be accompanied only by unreason-
ably high s2C=s
2
E . This implies that, at least when rDZ.
1
2
rMZ an
underlying additive model is more plausible than a highly epistatic
architecture. Specifically, as Table 1 illustrates, in highly heritable
traits with a small contribution of common variance, phantom
heritability is likely to be small.
As noted by Zuk et al. [13] in their supplementary information,
the amount of phantom heritability estimated depends on the
method of estimation of h2pop. The expected heritability estimate
from regression of offspring phenotype on mid-parental phenotype
(h2pop(PO)) is less than h
2
pop(ACE) under the kw1 basic LP model.
Other factors could also contribute to differences between
h2pop(ACE) and h
2
pop(PO) such as dominance and greater common
environment of sibling compared to filial relations. Despite this,
empirical observation ([7] pp. 172–173) does not, in general,
suggest large differences between h2pop(ACE) and h
2
pop(PO), which is
not consistent with an important role for phantom heritability
(although sampling variation about estimates make it difficult to
draw strong conclusions). Deconfounding of genetic and common
environmental variance is possible, for the most part, by use of
adopted away relatives. Very different estimates of correlations
Figure 1. Mean narrow-sense heritability (                                                                                   )   (panels A and B)     and  proportion of    phenotypic variance   which is commo
doi:10.1371/journal.pone.0068913.g001
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h2~s2A=s
2
P
2~s2C=s
2
Pfor           siblings     (                                                                                                    )          (panels C and D) across 50 simulation replicates color coded as function of MZ/DZ correlation and number
n
(c
of pathways (  ) under the basic LP model.k                   Given a combination of MZ/DZ correlations, a decrease in narrow-sense heritability (i.e., as k
grows), implies an increase in contribution of common environment.
between adopted away siblings and those raised together is
expected if phantom heritability is important, but adoption studies
tend to support genetic estimates from twin studies [22].
The Extended LP Model
Zuk et al. proposed a simple and elegant model that allows
exploration of the impact of epistasis on estimates of heritability
without needing to define epistasis between individual loci. In fact,
the basic LP model is a special case of the optimum pathway
model proposed by Sewall Wright in 1935 [23], in which the
expressed phenotype is the pathway value closest to a defined
optimum, which could be, for example, the mean or median,
rather than the maximum. These models include the additive
model as a special case, but produce different amounts of epistasis
as the number of pathways increases. Indeed any non-linear
transformation of an additive genetic model, even the infinitesimal
model, leads to non-additive variation; but Zuk et al. show that the
basic LP model generates a phenotypic distribution close to
normal, particularly when k is small. Under the basic LP model all
pathway phenotypes have the same distribution and pathway
heritabilities and pathways are uncorrelated. Biologically, these are
very strong assumptions, not least since they invoke the
infinitesimal model that implies independent contributions from
many genomic sites in each pathway, and so we extended the basic
LP model to allow correlated pathway phenotypes with different
distributions and pathway heritabilities. Phantom heritability was
little affected by differences in variance and heritability between
pathways. However, differences in mean phenotype and the
presence of positive correlations between pathways can decrease
the phantom heritability considerably, and negative correlations
increase it. Our results show how the predicted importance of
phantom heritability depends on implicit model assumptions, such
thatthe problem of phantom heritability could be overstated.-
Drawing inferences about epistasis from the LP model.
There is much debate about the relative importance of non-
additive versus additive genetic variance [24,25,26,21,27], sum-
marized by Crow [28]. Central to the debate is that mutational
studies demonstrate the ubiquity of epistasis in the classical sense,
because genes interact in hierarchical systems to generate
biological function [26]. However, in quantitative genetics it is
the residual variation segregating in populations that determines
differences amongst individuals not overall biological function
[26]. Fisher suggested that epistasis was not important because
usually there would be some scale transformation of phenotypic
values to generate additive effects [26]. Indeed, this is the basis of
models of complex disease where non-additivity on the observed
scale can be transformed to an underlying additive scale.
Furthermore, under mutation drift (neutral) models a high
proportion of genetic variants are at frequencies near 0 or 1, so
the presence of substantial epistatic interactions at the level of gene
effects does not in itself generate appreciable epistatic variance,
and contributions from epistatic interactions are detected as
Figure 2. Phantom heritability under the extended LP model as a function of (A) differences in mean (sd unit) of two pathway
phenotypes, (                                                              )     (B) changes in                                              while                                                                                                        ,      (C) pathway correlations for different number of pathways, and (D)
~2 ,  contribution of  common family environment is 
doi:10.1371/journal.pone.0068913.g002
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pathway correlations for different numbers of pathways assuming a total contribution of common environment of 10% for
e         Unless stated otherwise, number of pathways               
 
           each pathway phenotype.  
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additive variance [28,21]. These arguments are further strength-
ened under models that consider selection against mutations
deleterious for fitness with pleiotropic effects on quantitative traits
[29] as the proportion of variants with frequencies near 0 or 1 is
even higher. Zuk et al. [13] incorrectly state in their Supplemen-
tary Information that the derivation in Hill et al. [21] applies only
to pairs of loci, whereas in fact these wereused for illustration, and
the argument holds for multilocus epistasis. The elegance of the LP
model of Zuk et al. [13] is that it is parametrized in terms of
variances and so does not depend on the allele frequency
distribution. Zuk et al. [13] (supplement page 45) counter Hill et
al’s analysis by arguing that most genetic variants contributing to
complex traits cannot be at extreme frequencies because these
would generate little variance. They illustrate with a two-locus
example (their Supplementary Figure 9), but it shows a steep
increase in total genetic variance from minor allele frequency of 0
to 0.1, nearing its maximum for minor allele frequency 0.1, where
additive6 additive variance accounts for only 8% of the genetic
variance. Furthermore, because the distribution of heterozygosity
is approximately uniform over 0 to 1 under the neutral mutation
drift model, all frequencies are expected to contribute approxi-
mately equally to the variance under an additive model. Empirical
results also suggest that epistasis can generates little epistatic
variance. For example, although many substantial epistatic effects
have been detected for bristle number in Drosophila [30], bristle
number expresses mostly additive variance in populations [16]. At
face value these results may seem to be contradicted by recent
results of the Drosophila Genetics Research Panel (DGRP) entitled
‘‘Epistasis dominates the genetic architecture of Drosophila
quantitative traits’’ [31]. They reported data are from a GWAS
undertaken on the 168 DGRP lines [32] and on gene frequency
differences between pools of lines scoring high and low for
phenotypes following an advanced intercross (70 generations) from
40 of the DGRP lines [31]. They found no overlap of SNP
associated effects between the two analyses, which they interpreted
as presence of epistasis. However, the limited number of DGRP
lines are underpowered for association analysis and show long
range LD so effects of distantly located QTL are confounded and
are less likely to match those found in the intercross study. Also, as
the authors [31] note: ‘‘In fact, variation induced by all of the
epistatic interactions identified in the present study could be
largely explained by the marginal additive effects at the trait-
associated loci’’.
Limiting Pathways in Context
The LP model was justified (Zuk et al., p1193 [13]) without
reference as: ‘‘Here we show that simple and plausible models can
give rise to substantial phantom heritability. Biological processes
often depend on the rate-limiting value among multiple inputs,
such as the levels of components of a molecular complex required
in stoichiometric ratios, reactants required in a biochemical
pathway, or proteins required for transcription of a gene.’’ For
biochemical pathways, at least, metabolic control theory has
shown that ‘rate limiting steps’ are not a relevant concept, for rate
of flux is a continuous function of activities at multiple stages of the
pathway [33]. In a recent review Suarez and Moyes stated ‘‘The
days have long passed when it was simply assumed that enzymes
possessing allosteric regulatory properties were ‘rate-limiting’ [34].
It is now recognized that control of pathway flux is often
distributed among many enzymes.’’ And Fell’s well-cited review
[35] concludes ‘‘whatever criticisms might be made about any one
of the experimental studies, it is significant that none have
Table 1. Phantom heritability (h^2phantom), narrow-sense heritability (h^
2) and percentage of common variance (c^2) for three traits
assuming varying number of pathways (k) and pathway correlations (rpath).
Trait rMZ rDZ h
2
ACE k rpath h^
2
phantom h^
2 c^2
High-fat dairy intake 0.23 0.13 0.20 2 0 0.15 0.17 0.04
4 0 0.30 0.14 0.06
10 0 0.56 0.09 0.10
2 0.2 0.05 0.19 0.03
4 0.2 0.13 0.17 0.04
10 0.2 0.22 0.16 0.06
Triglyceride levels in
blood
0.55 0.28 0.54 2 0 0.25 0.41 0.07
4 0 0.49 0.28 0.16
10 0 0.74 0.14 0.29
2 0.2 0.16 0.45 0.05
4 0.2 0.28 0.39 0.09
10 0.2 0.38 0.33 0.15
Height 0.89 0.47 0.84 2 0 0.35 0.55 0.20
4 0 0.61 0.33 0.39
10 0 0.82 0.15 0.61
2 0.2 0.26 0.62 0.17
4 0.2 0.43 0.48 0.30
10 0.2 0.56 0.37 0.43
Illustrated for observed values of the estimated heritability h2ACE and underlying rMZ and rDZ , assuming a larger number of pathways implies higher phantom
heritability, lower narrow-sense heritability, but also a larger contribution of common variance. Higher pathway correlations reduce these effects.
doi:10.1371/journal.pone.0068913.t001
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provided support for the existence of unique ‘rate-limiting’
enzymes in pathways.’’ In quantitative genetic analysis of models
of such pathways, it has been shown that a substantial proportion
of the variance is additive [36].
The LP model was proposed to explain ‘‘missing heritability’’ in
complex traits. Methods are now available to estimate variance
attributable to all common genotyped SNPs rather than those
identified as significant [37,38]. Simulations conducted under the
LP model demonstrate that estimates of additive variance
attributable to SNPs calculated using GCTA [39] are unbiased
and not inflated by epistasis [40]. Applications of these methods to
real data show that at least 40% of heritability estimated from
family studies remains unexplained [41]. The number of
associated common variants detected has increased with sample
size [41] e.g., from 9 to 140 for Crohn’s Disease as case sample size
increased from 2000 [42] to w2000[43]. The implication is that,
to date, studies have been underpowered to detect common
variants of realistic effect sizes, but that many exist, given that rare
variants are much more prevalent, and that a very large number of
rare variants also contribute exist which individually explain little
variance but their cumulative contribution may be important.
Collection of empirical data to test an additive only model is
unlikely to be achievable in humans. In yeast, an elegant study
designed to explore contributions of variance from different
sources found substantial epistatic variance (median of 30%) for
some of the 46 traits studied [44]. However, its relevance to
human populations is limited, since all gene frequencies were one
half (two-way cross design), conditions under which epistasis is
likely to be maximized [21,28]. More relevant insight may be
gained from outbred species. For example, in dairy cattle
heritability and SNP associated effects are estimated from large
numbers of half-sib daughters born, raised and milked at different
farms. Therefore, their estimates are unlikely to be confounded
with non-additive genetic or shared environmental effects [45].
For milk yield 79% (s.e. 5%) of the additive genetic variance is
captured by SNPs [46]. That there is so little missing heritability
can be explained by the smaller effective population size leading to
longer linkage disequilibrium (LD) blocks than in humans and
hence even rare alleles can be predicted by multiple SNPs. Traits
that could reasonably be assumed to be under strong natural
selection (so that very rare variants play an important role), such as
fertility, have lower heritability (40%) and greater missing
heritability (55% explained by common SNPs fitted together)
[46]. The simplest explanation of why not all variance is explained
by the SNPs is that even in livestock some causal variants are rare
and in low LD with the SNPs. These results provide evidence that
(when h2pop is estimated accurately) additive effects can explain the
majority of observed variance in a complex trait in an outbred
population.
Disease Traits
Zuk et al. [13] expressed phantom heritability as
h2phantom~1{
h2
all
h2pop
. For quantitative traits h2all~h
2
Pmax
, where
h2Pmax is the proportion of variance in Pmax attributable to additive
genetic factors. For disease traits they considered a liability
threshold model, but did not assume disease to occur when the
liability phenotype Pmax exceeds the threshold truncated by the
proportion 2m, but instead defined disease to occur when a
pathway phenotype exceeds the threshold truncated by the
proportion 2m=k, generating a total proportion, 2m, of affected
individuals when summed over all k pathways. This definition
implies additional non-additive genetic variance, i.e., h2allvh2Pmax .
For example, using the 3-pathway model for Crohn’s Disease [13]
with h2path~0:476 and cpath~0:16 generates h
2
Pmax
~0:283, but
h2all~0:186 for 2m~0:001. Under the extended LP model we
showed for quantitative traits that results for a multiple pathway
model converged to a single pathway model for positively
correlated pathways; qualitatively this result also holds for disease
traits.
The LP model was justified by Zuk et al as limiting pathways in
a biological and biochemical sense. However, the same method-
ological approach could represent a heterogeneity model, gener-
ating a different interpretation of results. Under the LP model the
final phenotype is considered the ‘‘true’’ phenotype and the non-
additive genetic variance h2pop{h
2
all is real. In contrast, under a
heterogeneity model, the pathways are the true phenotypes but
inadequacies in phenotyping cause an inability to distinguish
between biologically different classes of the observed disease.
Hence, under a heterogeneity model, the measurable additive
genetic variance h2all may be much less than true additive variance
of each subtype, but mostly h2pop{h
2
all could be viewed as
‘‘phantom non-additive genetic variance’’, since the non-additive
genetic variance results only from incorrectly treating multiple
phenotypes as a single trait. In common complex genetic disease
there have been notable advances in separation of diseases that
originally were considered a single diagnostic class, e.g., diabetes,
rheumatoid arthritis, breast cancer. Dilution of allelic effect size is
a consequence of phenotypic heterogeneity in genetic association
studies. For example, differentiation of breast cancer into ER-
positive and ER-negative cancers has identified associated loci not
possible from combining the case cohorts [47]. In psychiatric
nosology it has long been recognized that diagnostic classes are
likely to overarch heterogeneous etiology, recently explored in
light of results from genomic studies [48]. Indeed, one motivation
of genomic studies is to allow genetically informed nosology.
Conclusion
The results of Zuk et al. [13] provide a timely reminder of the
well-recognized limitations of analyses based on twin and family
data, which are often underpowered to separate additive genetic
from common environmental effects [49] and non-additive effects.
The (extended) LP model provides a useful framework to explore
the possible contribution of non-additive genetic variance to
complex traits. An important role for non-additive genetic action is
attractive because gene interactions are ubiquitous at the
functional level, yet this does not necessarily translate to important
epistatic variance over and above variance detected as additive
effects. For disease traits, empirical data can only be explained by
non-additivity on the disease scale, but such non-additivity can be
explained by scale transformations without needing to invoke
more complex models. Using the framework of the extended LP
model, and together with theoretical, empirical, and pragmatic
arguments we conclude that although contributions from non-
additive variance may be commonplace in complex traits, the
contribution of additive genetic variance is likely to be much more
important than that of non-additive variance. Ultimately, only
empirical results can provide a satisfactory conclusion to the
debate of missing heritability, but these may be elusive. Larger
sample sizes should afford the power to identify common variants
of smaller effect size and two-locus interactions. However, the
heavy penalty of multiple testing will not allow exploration of
higher order epistatic interactions implied by the LP model.
Likewise, large sample sizes are unlikely to identify rare causal
variants of small effect, since rare variants are likely to be
population specific and large sample sizes from homogenous
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ethnic groups simply may not exist. Zuk et al. [13] suggest a
methodology for estimation of h2all , but the required cohorts (large
and from isolated populations) are also difficult to achieve. For
disease traits the most tractable approach may be collection of
large, informatively phenotyped cohorts to provide the building
blocks that may allow clustering of cases based of combinations of
genetic risk variants to be mapped onto phenotypic heterogeneity.
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